Digital Health Startups

My Mobile MD provides mobile physician services with onsite providers to deliver primary and urgent care directly to patients, emphasizing personalized treatment plans and direct provider relationships outside traditional healthcare settings.

1 investor

Telemynd is a mental healthcare platform that connects patients with licensed providers through a human-centered approach, prioritizing privacy and continuity of care while using technology to reduce administrative burden and improve access.

1 investor

Mynurva delivers mental health support services for employees, organizations, universities, and charities, combining clinical expertise with digital platforms to make therapy accessible across the UK and MENA region.

1 investor

Myolex develops a portable, non-invasive muscle assessment device based on electrical impedance myography (EIM) that measures single-muscle composition and structure to aid diagnosis, prognosis, and treatment monitoring of neuromuscular and musculoskeletal diseases such as ALS. It serves clinicians, researchers, and pharmaceutical companies, with applications in clinical trials and at-home patient monitoring.

1 investor

Myontec develops wearable technology (MShorts Plus and MSleeves) that monitors muscle activation and load in real time across quadriceps, hamstrings, glutes, and adductors for team sports athletes and coaches focused on performance optimization and injury prevention.

1 investor

Myota makes prebiotic fibre supplements that blend multiple clinically tested fibre sources into a daily scoop to support gut microbiome health, blood sugar control, cholesterol, digestion, and cognitive function. Sold direct to consumers, the products include a general blend and a "Sensitive" low-FODMAP formulation for people with digestive issues.

1 investor

Peri is a wearable device and app that passively tracks perimenopause symptoms such as hot flashes, night sweats, anxiety, and sleep disturbances, combining symptom, activity, and lifestyle data to deliver personalized management insights. It serves women going through perimenopause and is currently available in the US.

1 investor

Myriad provides germline and tumor genomic testing across hereditary cancer, prenatal and reproductive health, prostate cancer, and pharmacogenomics for mental health medications. It supplies patients and healthcare providers with genetic screening results and AI-derived insights to inform diagnosis, risk assessment, and treatment decisions.

1 investor

MySecondEar is Germany's leading digital hearing aid provider, offering hearing devices, accessories, and professional fitting services both online and at physical locations. The company serves customers seeking accessible, transparent hearing solutions through a combination of digital and in-person support.

1 investor

MyTrials provides a platform helping patients and families navigate and find clinical trials through AI-driven technology. The service addresses the complexity of trial discovery for individuals seeking medical research participation opportunities.

1 investor

MyUTI is a platform providing UTI testing and support services for women with frequent and stubborn urinary tract infections. The company addresses gaps in women's health diagnostics and treatment by offering reliable testing solutions and clinical guidance.

1 investor

My Well Self is an online wellness care navigation platform that bridges conventional and complementary medicine to improve health outcomes and reduce preventable chronic conditions for individuals, employers, and governments.

1 investor

Based on the page listing "Ophthalmic Pharmaceutical Consultant" and "Chief Clinical Officer" roles, Nacuity appears to be a pharmaceutical company focused on ophthalmology (eye care), though the page provides insufficient detail to confirm products, customer base, or market focus.

1 investor

Rylo builds accessibility tools for Deaf and hard of hearing people, providing real-time communication solutions that preserve the richness of speech and integrate sign language research. The company serves the aging, deaf, and hard of hearing communities through dedicated support and community-centered product development.

1 investor

Naitur provides AI automation solutions for independent health and wellness practices to improve client acquisition and operational efficiency. The company also collaborates with mental health research labs to build AI automation solutions that accelerate scientific discovery.

1 investor

Nanodropper makes an FDA-listed, sterile twist-on adaptor that attaches to eyedrop bottles to dispense smaller drops, reducing medication waste and extending bottle life. It serves patients using glaucoma, dry eye, cataract, and myopia eyedrops, as well as optometry and ophthalmology clinics.

1 investor

Nara provides software for home care providers that captures patient encounters (intakes, follow-ups, and phone check-ins), generates care plans, visit notes, and other documentation in an agency's format, and syncs the information into care management software and EMRs. It also lets care teams query insights on care recipients and draft communications, with HIPAA-compliant data handling.

1 investor

The Cancer Network is a nonprofit organization that educates LGBTQIA+ communities about cancer risks and screening, trains healthcare providers in culturally competent care, and advocates for LGBTQIA+ cancer survivors. The organization delivers direct patient services, policy advocacy, and training programs to improve health outcomes and support for LGBTQIA+ individuals across the cancer care continuum.

1 investor

National Medical Funding Services provides hospitals with solutions to improve administrative efficiency on denied claims, accelerate claim payments, and enhance financial visibility within their revenue cycle operations.

1 investor

naturalX publishes a research report and consumer health market map for 2026, analyzing trends such as wearables, GLP-1 services, and the shift toward consumer-driven healthcare. It compares consumer health ecosystems and companies across the US and Europe.

1 investor

Natus Sensory develops medical devices and solutions to screen, diagnose, and treat disorders affecting the brain, neural pathways, and sensory nervous systems. The company serves healthcare providers and patients worldwide and maintains manufacturing sites across multiple countries with ISO and FDA certifications.

1 investor

Navigate Maternity offers NavigateHER, a pregnancy care platform that combines connected health monitoring (blood pressure, weight, and mood tracking via pregnancy-validated devices), trimester-based education, emotional and social screenings, and local support resources for pregnant women. It provides covered pregnancy essentials such as blood pressure cuffs, compression garments, and breast pumps through insurance.

1 investor

NavigateMD operates a platform that connects people with disabilities and their families to medical providers, businesses, non-profit organizations, and other resources matched to their needs. It serves the intellectual and developmental disability (I/DD) community, helping them find care and support services.

1 investor

Navigene develops AI-enabled diagnostic tests using proprietary processes and lab automation, focusing on accurate, affordable, next-generation diagnostics. It serves patients by offering precise testing along with disease management counseling.

1 investor